Founder members

Juran Kato　Ph.D.
President and CEO 


Appointments/Education：
2017  Associate Director, Innovation and Entrepreneurship
Takeda Pharmaceutical Company Limited
2012  Associate Director, Extra Value Generation Drug Discovery Unit
Takeda Pharmaceutical Company Limited
2006  Principal Scientist Oncology Drug Discovery Unit
Takeda Pharmaceutical Company Limited
2000  Assistant Researcher, Postdoctoral fellow
University of California, Los Angeles
2000  Ph.D. (Molecular Biology), Tokyo Institute of Technology
1996  Lecturer, International Christian University

Honor/Awards：
Drug Discovery Unit Head Award, Research Division Head Award, Department Head Award (Takeda Pharmaceutical Company Limited)
Brigid G. Leventhal Scholars in Cancer Research Award for the promising female researcher (AACR)

Patent：
1 substance patent
1 utility patent

Selected publications：
1) Signal Transduction Second Edition (article in Japanese) Ed Y. Kaziro and Satoh (2011) MDSi
2) Career path 101 for PhDs in Bioscience Majors (article in Japanese) Ed. Miura and Sengoku (2009) Yodosha

Mami Ojima
Chief Knowledge Officer


Appointments/Education：
2017  Principal Scientist, Innovation and Entrepreneurship
Takeda Pharmaceutical Company Limited
1997  Principal Scientist, Cardiovascular and Metabolic Diseases Drug Discovery Unit
Takeda Pharmaceutical Company Limited
1980  Research Scientist, Cardiovascular Diseases Pharmacology Unit
Takeda Pharmaceutical Company Limited
1980  College of Medical Technology,Kyoto University

Honor/Awards：
Takeda Global Award, Pharmacology Department Head Award, 1989 President Award (Takeda Pharmaceutical Company Limited)

Patent：
More than 1 substance and utility patent

Selected publications:
1) Ojima et al., 2011, J Pharmacol Exp Ther.
2) Ojima et al., 1997, Eur J Pharmacol.
3) Ojima et al., 1996, Jpn Pharmacol Ther.

Lili Mao　Ph. D.
Chief Science Officer


Appointments/Education：
2017  Principal Scientist, Innovation and Entrepreneurship
Takeda Pharmaceutical Company Limited
2015  Postdoctoral Fellow, Extra Value Generation Drug Discovery Unit
Takeda Pharmaceutical Company Limited
2012  Postdoctoral Associate, University of Minnesota
2010  Research Associate, Postdoctoral Fellow, Rutgers University
2010  Ph.D. (Biochemistry) University of Medicine and Dentistry of New Jersey

Honor/Awards：
2011, 2010, Technical Highlight, PSI/Nature Structural Biology Knowledgebase

Patent：
2 Technological inventions

Selected publications:
1) Mao et al., 2013, Encyclopedia of Biophysics
2) Mao et al., 2012, Methods in Molecular Biology
3) Mao et al., 2010, J. Struct Funct Genomics
4) Hosomi et al., 2018, An integrative approach using real-world data to identify alternative  therapeutic uses of existing drugs, Plos ONE

Takako Naito
Chief
Research Alliance

Katsuo Midoro  D.V.M., Ph.D.
Chief
Quality Assurance

Other members

Akiko Oka
General Affairs
Executive Secretary

Kazuo Maruhashi　Ph.D.
Senior Advisor
Chemistry, Manufacturing, and Control (CMC)

Current affiliate：
Advisor, Chemical Trading Company and CRO
Researcher, Graduate School of Pharmaceutical Sciences
Faculty of Pharmaceutical Sciences, Tokyo University

Appointments/Education：
2008  Ace Japan (Manufacturing control of APIs, Process development）
2007  Mitsubishi Corporation（China R&D division、Process development）
1991  Taiho Pharma（Quality control of APIs for clinical studies）
1979  Wako Pure Chemical Corporation（Examining manufacture processes)

Takeshi Hirayama
Senior Advisor
Business strategy

Consultant

Guido Hanauer　D.V.M., Ph.D.
Advisor
Translational medicine
Clinical development

Science Medical Officer

Masayuki Ito　M.D., Ph.D.
Chief Science Medical Officer
Department of Mental Retardation and Birth Defect Research